Results 171 to 180 of about 9,786 (244)

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

, 2013
Jae Wook Lee, Sung‐Soo Yoon, Zexiang Shen, Arnold Ganser, Hui‐Chun Hsu, A. El-Ali, Dany Habr, Nicholas G. Martin, John B. Porter   +8 more
openalex   +2 more sources

International sentinel site surveillance of patients with transfusional hemosiderosis treated with deferasirox in actual practice setting [PDF]

, 2018
Amal El‐Beshlawy, Baba Inusa, David Beneitez Pastor, Blanca Xicoy, Maria Soledada Duran Nieto, Andreas Bruederle, Amin Azmon, Geralyn Gilotti, Mohsen Saleh Elalfy   +8 more
openalex   +1 more source

Beyond blood transfusions: exploring iron chelation therapies in transfusion-dependent beta-thalassemia. [PDF]

Ann Med Surg (Lond)
Talha M, Ali MH, Hurjkaliani S, Rahmat ZS, Sadia H, Hasibuzzaman MA, Uzair AUQ.   +6 more
europepmc   +1 more source

LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

, 2014
Ashraf Soliman, Mohamed A. Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis   +6 more
openalex   +2 more sources

Targeted active surveillance of branded generic deferasirox in pediatric thalassemia patients in a tertiary care hospital of India: A pharmacovigilance study.

Indian J Pharmacol
Panigrahi M, Swain TR, Jena RK, Panigrahi A, Debta N.   +4 more
europepmc   +1 more source

Successful case of deferasirox slow desensitization in adults. [PDF]

Allergol Select
Basa Akdogan B, Koca Kalkan I, Koycu Buhari G, Ozdedeoğlu O, Ates H, Aksu K, Oner Erkekol F.   +6 more
europepmc   +1 more source

Deferasirox versus deferoxiamine for the treatment of transfusional iron overload in patients with β-thalassemia major

, 2014
Osama Ahmed Ibrahiem, Ahmad M. Thabet
openalex   +1 more source

Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trial. [PDF]

Lancet Reg Health Southeast Asia
Premawardhena A, Wanasinghe S, Perera C, Wijethilaka MN, Rajakaruna RHMG, Samarasinghe RANKK, Williams S, Mettananda S.   +7 more
europepmc   +1 more source

The challenges of handling deferasirox in sickle cell disease patients older than 40 years [PDF]

, 2019
Lorena Bedotti Ribeiro, Eliane Alves Soares, Fernando Ferreira Costa, Simone Cristina Olenscki Gilli, Sara Teresinha Olalla Saad, Bruno Deltreggia Benites   +5 more
openalex   +1 more source

<i>Candida albicans</i> enhances iron uptake to maintain fluconazole resistance. [PDF]

Infect Immun
Sharma R, Nahar A, Puri S.
europepmc   +1 more source